Results 41 to 50 of about 754,719 (161)

Creating and validating a patient-reported outcome instrument for women with vulvar neoplasia after surgical treatment : a mixed-methods project [PDF]

open access: yes, 2012
In vulvar neoplasia, substantial improvements in therapy and care have been attained during the last decades.1 Nevertheless even minor surgical interventions cause multiple symptoms and side effects that impact women’s quality of life.2 The term ...
Senn, Beate
core   +1 more source

Vulvar and vaginal cancer during pregnancy: A pooled analysis of 15 cases from the International Network on Cancer, Infertility and Pregnancy and review of the literature

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 11, Page 2187-2199, November 2025.
Vulvovaginal cancer in pregnancy is rare. This pooled analysis of 15 INCIP cases and 83 cases from the literature highlights the underuse of nodal imaging, the value of multidisciplinary care, and shows that standard oncologic treatment can be safely adapted without compromising maternal or fetal outcomes.
Charlotte L. LeJeune   +12 more
wiley   +1 more source

Prognosis of vulval cancer with lymph node status and size of primary lesion: A survival study

open access: yesJournal of Mid-Life Health, 2014
Introduction: Squamous cell cancer of the vulva is a rare disease with an annual incidence of two to three per 100,000 women. Lymph node metastasis is the most important prognostic factor for the recurrence and survival in vulval carcinoma. Materials and
Pankaj Deka   +5 more
doaj   +1 more source

Comprehensive management of vulvovaginal cancers

open access: yesCA: A Cancer Journal for Clinicians, Volume 75, Issue 5, Page 410-435, September/October 2025.
Abstract Vulvar and vaginal cancers represent rare malignancies, with an incidence of 2.7 per 100,000 women for vulvar cancer, predominantly affecting women older than 60 years, although rising rates are observed in younger demographics. Approximately 90% of vulvar cancers are squamous cell carcinoma and frequently are associated with human ...
Angélica Nogueira‐Rodrigues   +5 more
wiley   +1 more source

Radical vulvectomy - a retrospective study

open access: yes, 2015
Teoretická část diplomové práce na téma Radikální vulvektomie retrospektivní studie je rozdělena do čtyř kapitol. První kapitola je zaměřena na anatomii pohlavních orgánů ženy včetně anatomie lymfatického systému vulvy.
Hrubošová, Tereza
core   +1 more source

Case Report on Leiomyosarcoma of the Vulva: A Rare Pathology

open access: yesMarshall Journal of Medicine, 2020
Leiomyosarcoma (LMS) of the vulva is rare. However it is the most common histologic subtype of vulvar sarcoma, accounting for approximately 1% of all vulvar malignancies.
Samantha A. Smith   +3 more
doaj   +1 more source

Cancer of the vulva: 2025 update

open access: yesInternational Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 36-47, September 2025.
Abstract Vulvar cancer is an uncommon gynecological malignancy primarily affecting postmenopausal women. No specific screening exists and the most effective strategy to reduce the incidence of vulvar cancer is the opportune treatment of predisposing and preneoplastic lesions associated with its development.
Alexander B. Olawaiye   +3 more
wiley   +1 more source

Morbidity following Surgical Management of Vulval Cancer.

open access: yesOnline Journal of Health & Allied Sciences, 2012
The objective of this study was to know the complications following vulvectomy and inguinofemoral lymphadenectomy including the time taken to complete wound healing.
Gurubasavanagoud Y   +5 more
doaj  

Verrucous carcinoma of the vulva: diagnosis and treatment [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2017
: Vulvar cancer accounts for less than 1% of malignancies in women. Verrucous carcinoma of the vulva is a rare histological variation, comprising less than 1% of vulvar cancer cases.
Adriana Bittencourt Campaner   +3 more
doaj   +1 more source

Assessing the impact of multidisciplinary team gynecological oncology care in Botswana: A potential model for low‐ and middle‐income countries

open access: yesCancer, Volume 131, Issue 16, 15 August 2025.
Abstract Background In Botswana, a multidisciplinary team (MDT) clinic was established in 2015 to streamline care for all patients with gynecological malignancies including cervical cancer, Botswana’s leading cause of cancer mortality. Methods Patients presenting at the MDT clinic in Gaborone, Botswana, were prospectively enrolled.
Emily MacDuffie   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy